Consultiva Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Consultiva Wealth Management's IBB Position: Q3 2026 in Review
Consultiva Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 50% in Q3 2026, selling an estimated $20.1K and leaving 100 shares worth $21.1K. The position accounts for 0.05% of the portfolio, ranked #161.
Consultiva Wealth Management first reported a position in IBB in Q4 2021 and has held it in 15 quarters since. The position peaked at $38K in Q2 2026. 1,026 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Consultiva Wealth Management held 100 shares of iShares Biotechnology ETF worth $21.1K as of Q3 2026.
- Consultiva Wealth Management sold 100 iShares Biotechnology ETF shares in Q3 2026, an estimated $20.1K.
- iShares Biotechnology ETF made up 0.05% of Consultiva Wealth Management's portfolio in Q3 2026, its #161 holding.
- Consultiva Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 15 quarters since.
- Consultiva Wealth Management's iShares Biotechnology ETF position peaked at $38K in Q2 2026.
- 1,026 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Consultiva Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.